Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Evogene (EVGN) Gross Profit (2016 - 2025)

Historic Gross Profit for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to $155000.0.

  • Evogene's Gross Profit fell 7779.37% to $155000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 4849.81%. This contributed to the annual value of $3.2 million for FY2024, which is 1902.23% down from last year.
  • As of Q3 2025, Evogene's Gross Profit stood at $155000.0, which was down 7779.37% from $748000.0 recorded in Q2 2025.
  • Evogene's Gross Profit's 5-year high stood at $3.9 million during Q1 2024, with a 5-year trough of $7000.0 in Q2 2021.
  • Over the past 5 years, Evogene's median Gross Profit value was $269000.0 (recorded in 2024), while the average stood at $648052.6.
  • Its Gross Profit has fluctuated over the past 5 years, first plummeted by 9619.57% in 2021, then skyrocketed by 111630.09% in 2024.
  • Over the past 5 years, Evogene's Gross Profit (Quarter) stood at $44000.0 in 2021, then soared by 572.73% to $296000.0 in 2022, then plummeted by 39.19% to $180000.0 in 2023, then surged by 375.56% to $856000.0 in 2024, then crashed by 81.89% to $155000.0 in 2025.
  • Its Gross Profit stands at $155000.0 for Q3 2025, versus $748000.0 for Q2 2025 and $830000.0 for Q1 2025.